Evidence map›Paper›PMID 31262953›Full record

ArticleJournal of clinical pathology2019

Developing a pan-cancer research autopsy programme.

Prashant Bavi, Madura Siva, Tarek Abi-Saab, Dianne Chadwick, Neesha Dhani, Jagdish Butany, Anthony M Joshua, Michael H Roehrl

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Prashant BaviDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Madura SivaDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Tarek Abi-SaabDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Dianne ChadwickDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Neesha DhaniDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Jagdish ButanyDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Anthony M JoshuaDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada roehrlm@mskcc.org anthony.joshua@doctor.com.
Michael H RoehrlDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA roehrlm@mskcc.org anthony.joshua@doctor.com.ORCID http://orcid.org/0000-0003-4892-1098
University Health Network · CAGarvan Institute of Medical Research · AUMemorial Sloan Kettering Cancer Center · USPrincess Margaret Cancer Centre · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

aimsRapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre.

methodsAdvanced-stage cancer patients, most commonly inpatients in palliative care facilities, were approached to participate in a cancer research autopsy programme with the goal of acquiring multidimensionally annotated tissue for cancer research. On death of an enrolled patient, a predetermined notification plan was enacted, with the medical oncologist/clinical research coordinator informing a team of pathologists, researchers and allied staff. Quality assurance metrics were measured. Thereafter, tissues were annotated in a tissue bioinformatics database and linked to electronic patient records. All banked tissues were reviewed for tumour integrity, including DNA and RNA quality.

resultsOver 100 rapid research autopsies from diverse cancer sites were performed, and specimens were procured and annotated with detailed clinical information, including treatment and response. Tissues were successfully enabling studies of tumour immunology, xenografts, genomics and proteomics.

conclusionsLarge-scale rapid procurement and biobanking of cancer tissues from a rapid autopsy programme is feasible. Multidisciplinary integration between health and administrative staff from medical oncology, palliative care, pathology and biospecimen sciences is critical for the success of this challenging endeavour.

Indexed as

Medical OncologyPathology, SurgicalTissue BanksAdultAgedAged, 80 and overAutopsyFemaleGenomicsHumansMaleMiddle AgedNeoplasmsPalliative CareProteomicsYoung Adultautopsy pathologycancer researchoncologysurgical pathology

Identifiers

PMID31262953
PMCPMC6817699
OpenAlexW2953440485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.